https://neurenpharma.com/prader-willi-syndrome 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/compassionate-use 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/corporate-governance 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/analyst-coverage 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/nnz-2591published-studies-and-presentations-pitt-hopkins-syndrome 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/nnz-2591published-studies-and-presentations-angelman-syndrome 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/syngap1 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/privacy-policy 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/about-us 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/announcements 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/activity-updates 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/team 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/company-values 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/products 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/nnz-2591 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/science 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/daybue 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/phelan-mcdermid-syndrome 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/angelman-syndrome 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/pitt-hopkins-syndrome 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/hypoxic-ischemic-encephalopathy 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/shareholder-services 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/pipeline 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com 2026-05-11T06:37:57Z daily 1.0 https://neurenpharma.com/investor-presentations 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/executive-management 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/corporate-directory 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/daybue-trofinetide 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/annual-and-interim-reports 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/rett-syndrome 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/other-programs 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/scientific-publications-and-presentations 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/nnz-2591published-studies-and-presentations 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/investor-dashboard 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/share-price-info 2026-05-11T06:37:57Z weekly 0.8 https://neurenpharma.com/our-science 2026-05-11T06:37:57Z weekly 0.8